XML 45 R28.htm IDEA: XBRL DOCUMENT v3.20.2
Stock-Based Payments (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Stock Options/SARs, Employee Stock Purchase Plan (ESPP), Restricted Stock and Restricted Stock Units and Performance Units Disclosures [Line Items]        
Stock-Based Compensation Expenses $ 33,811 $ 54,670 $ 113,454 $ 132,323
Common Shares Available for Grant 2,000,000.0   2,000,000.0  
Stock Options And SARs        
Stock Options/SARs, Employee Stock Purchase Plan (ESPP), Restricted Stock and Restricted Stock Units and Performance Units Disclosures [Line Items]        
Stock-based compensation expense related to stock options, SAR and ESPP grants $ 23,500 $ 20,400 $ 52,600 $ 47,800
Unrecognized compensation expense $ 63,700   $ 63,700  
Weighted average period over which unrecognized compensation expense will be recognized (in years)     2 years 3 months 18 days  
Weighted Average Fair Values And Valuation Assumptions Used To Value Stock Option/SARs, ESPP, and Performance Units/Stock Stock-Based Compensation [Abstract]        
Weighted Average Fair Value of Grants (price per share)     $ 11.06 $ 19.49
Expected Volatility (in hundredths)     44.46% 32.01%
Risk-Free Interest Rate (in hundredths)     0.21% 1.69%
Dividend Yield (in hundredths)     3.27% 1.39%
Expected Life (in years)     5 years 2 months 12 days 5 years 1 month 6 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]        
Outstanding at January 1 (in shares)     9,395,000 8,310,000
Granted (in shares)     1,993,000 1,946,000
Exercised (1) (in shares) [1]     (23,000) (586,000)
Forfeited (in shares)     (1,077,000) (200,000)
Outstanding at September 30 (2) [2] 10,288,000 9,470,000 10,288,000 9,470,000
Stock Options and SARs Vested or Expected to Vest (3) (in shares) [3] 9,963,000 9,127,000 9,963,000 9,127,000
Stock Options and SARs Exercisable at September 30 (4) (in shares) [4] 6,389,000 5,307,000 6,389,000 5,307,000
Intrinsic Value of Stock Options/SARs Exercised [1]     $ 400 $ 13,300
Intrinsic Value of Stock Options/SARs Outstanding [2] $ 10 $ 4,800 $ 10 $ 4,800
Weighted Average Remaining Contractual Life for Stock Options/SARs Outstanding (in years) [2]     4 years 6 months 4 years 6 months
Intrinsic Value of Stock Options/SARs Vested or Expected to Vest [3] 10 4,800 $ 10 $ 4,800
Weighted average remaining contractual life for stock options/SARs vested or expected to vest (in years) [3]     4 years 6 months 4 years 6 months
Aggregate Intrinsic Value for Exercisable Units [4] $ 0 $ 4,700 $ 0 $ 4,700
Weighted average remaining contractual life for exercisable options/SARs (in years) [4]     3 years 4 months 24 days 3 years 3 months 18 days
Weighted Average Grant Price Stock Option and SARs [Rollforward]        
Outstanding at January 1 (price per share)     $ 94.53 $ 96.90
Granted (price per share)     37.62 75.43
Exercised (1) (price per share) [1]     69.59 61.19
Forfeited (price per share)     88.54 104.89
Outstanding at September 30 (2) [2] $ 84.19 $ 94.53 84.19 94.53
Vested or Expected to Vest (3) (price per share) [3] 84.86 91.51 84.86 91.51
Exercisable at September 30 (4) [4] $ 96.53 $ 94.08 96.53 94.08
ESPP        
Weighted Average Fair Values And Valuation Assumptions Used To Value Stock Option/SARs, ESPP, and Performance Units/Stock Stock-Based Compensation [Abstract]        
Weighted Average Fair Value of Grants (price per share)     $ 18.96 $ 22.83
Expected Volatility (in hundredths)     55.53% 34.83%
Risk-Free Interest Rate (in hundredths)     0.83% 2.28%
Dividend Yield (in hundredths)     2.35% 1.04%
Expected Life (in years)     6 months 6 months
Restricted Stock And Restricted Stock Units        
Stock Options/SARs, Employee Stock Purchase Plan (ESPP), Restricted Stock and Restricted Stock Units and Performance Units Disclosures [Line Items]        
Unrecognized compensation expense $ 199,200   $ 199,200  
Weighted average period over which unrecognized compensation expense will be recognized (in years)     1 year 10 months 24 days  
Share-Based Compensation Arrangement By Restricted Stock And Restricted Stock Units Compensation Cost $ 4,600 $ 24,700 $ 52,800 $ 71,100
Restricted Stock/Restricted Stock Units and Performance Units [Roll Forward]        
Outstanding at January 1 (in shares)     4,546,000 3,792,000
Granted (in shares)     1,440,000 1,728,000
Released (1) (in shares) [5]     (1,139,000) (732,000)
Forfeited (in shares)     (63,000) (129,000)
Outstanding at September 30 (3) [6] 4,784,000 4,659,000 4,784,000 4,659,000
Intrinsic value released during the year [5]     $ 44,500 $ 61,200
Aggregate intrinsic value of stock and units outstanding [6] $ 171,900 $ 345,800 $ 171,900 $ 345,800
Weighted Average Grant Price Restricted Stock and Restricted Stock Units [Roll Forward]        
Outstanding at January 1 (price per share)     $ 90.16 $ 96.64
Granted (price per share)     38.16 80.12
Released (2) (price per share) [5]     85.94 97.51
Forfeited (price per share)     90.00 97.81
Outstanding at September 30 (3) (price per share) [6] $ 75.51 $ 90.34 $ 75.51 $ 90.34
Performance Unit        
Stock Options/SARs, Employee Stock Purchase Plan (ESPP), Restricted Stock and Restricted Stock Units and Performance Units Disclosures [Line Items]        
Stock-Based Compensation Expenses $ 5,700 $ 9,600 $ 8,100 $ 13,400
Unrecognized compensation expense $ 8,100   $ 8,100  
Weighted average period over which unrecognized compensation expense will be recognized (in years)     2 years 2 months 12 days  
Restricted Stock/Restricted Stock Units and Performance Units [Roll Forward]        
Outstanding at January 1 (in shares)     598 539
Granted (in shares)     172 172
Granted for Performance Multiple (1) [7]     66 72
Released (1) (in shares) [8]     (223) (185)
Forfeited (in shares)     0 0
Outstanding at September 30 (3) [9] 613 [10] 598 613 [10] 598
Intrinsic value released during the year     $ 12,900 [8] $ 15,400
Aggregate intrinsic value of stock and units outstanding [9] $ 22,000 $ 44,400 $ 22,000 $ 44,400
Weighted Average Grant Price Restricted Stock and Restricted Stock Units [Roll Forward]        
Outstanding at January 1 (price per share)     $ 92.19 $ 101.53
Granted (price per share)     37.44 75.09
Granted for Performance Multiple (1) (in dollars per share) [7]     100.95 69.43
Released (2) (price per share) [8]     88.52 94.63
Forfeited (price per share)     0 0
Outstanding at September 30 (3) (price per share) [9] $ 79.10 $ 92.19 $ 79.10 $ 92.19
Performance Units and Performance Stock Disclosures [Abstract]        
Performance Period for Performance Units and Shares     3 years  
Minimum Performance Multiple at the Completion of the Performance Period     0.00%  
Maximum Performance Multiple at the Completion of the Performance Period     200.00%  
Performance Multiple Applied at the Completion Period [7]     150.00% 200.00%
Minimum Performance Units and Stock Allowed to be Outstanding [10]     77  
Maximum Performance Units Allowed to be Outstanding [10]     1,149  
Lease and Well        
Stock Options/SARs, Employee Stock Purchase Plan (ESPP), Restricted Stock and Restricted Stock Units and Performance Units Disclosures [Line Items]        
Stock-Based Compensation Expenses $ 9,300 $ 13,300 $ 39,500 $ 40,600
Gathering and Processing Costs        
Stock Options/SARs, Employee Stock Purchase Plan (ESPP), Restricted Stock and Restricted Stock Units and Performance Units Disclosures [Line Items]        
Stock-Based Compensation Expenses 200 300 900 800
Exploration Costs        
Stock Options/SARs, Employee Stock Purchase Plan (ESPP), Restricted Stock and Restricted Stock Units and Performance Units Disclosures [Line Items]        
Stock-Based Compensation Expenses 1,000 5,200 15,000 18,100
General and Administrative        
Stock Options/SARs, Employee Stock Purchase Plan (ESPP), Restricted Stock and Restricted Stock Units and Performance Units Disclosures [Line Items]        
Stock-Based Compensation Expenses $ 23,300 $ 35,900 $ 58,100 $ 72,800
[1] The total intrinsic value of stock options/SARs exercised during the nine months ended September 30, 2020 and 2019 was $0.4 million and $13.3 million, respectively. The intrinsic value is based upon the difference between the market price of EOG's common stock on the date of exercise and the grant price of the stock options/SARs.
[2] The total intrinsic value of stock options/SARs outstanding at September 30, 2020 and 2019 was $0.01 million and $4.8 million, respectively. At September 30, 2020 and 2019, the weighted average remaining contractual life was 4.5 years and 4.5 years, respectively.
[3] The total intrinsic value of stock options/SARs vested or expected to vest at September 30, 2020 and 2019 was $0.01 million and $4.8 million, respectively. At September 30, 2020 and 2019, the weighted average remaining contractual life was 4.5 years and 4.5 years, respectively.
[4] The total intrinsic value of stock options/SARs exercisable at September 30, 2020 and 2019 was zero and $4.7 million, respectively. At September 30, 2020 and 2019, the weighted average remaining contractual life was 3.4 years and 3.3 years, respectively.
[5] The total intrinsic value of restricted stock and restricted stock units released during the nine months ended September 30, 2020 and 2019 was $44.5 million and $61.2 million, respectively. The intrinsic value is based upon the closing price of EOG's common stock on the date the restricted stock and restricted stock units are released.
[6] The total intrinsic value of restricted stock and restricted stock units outstanding at September 30, 2020 and 2019 was $171.9 million and $345.8 million, respectively.
[7] Upon completion of the Performance Period for the performance units granted in 2016 and 2015, a performance multiple of 150% and 200%, respectively, was applied to each of the grants resulting in additional grants of performance units in February 2020 and February 2019, respectively.
[8] The total intrinsic value of performance units released during the nine months ended September 30, 2020 and 2019 was $12.9 million and $15.4 million, respectively. The intrinsic value is based upon the closing price of EOG's common stock on the date the performance units are released.
[9] The total intrinsic value of performance units outstanding at September 30, 2020 and 2019 was approximately $22.0 million and $44.4 million, respectively.
[10] Upon the application of the relevant performance multiple at the completion of each of the remaining Performance Periods, a minimum of 77 and a maximum of 1,149 performance units could be outstanding.